Biosis Healing chairman Zhao Bo won Beijing top science and technology award

by



On Nov. 19, Beijing Municipal Science & Technology Award Studio announced the nominations for the 2020 Beijing Science and Technology Award, according to the website of the Beijing Municipal Science&Technology Commission. A total of 31 people have been nominated for the Zhongguancun Award for Outstanding Contribution, the highest award for science and technology in Beijing, according to the public list of nominations.




The Zhongguancun Award for Outstanding Contribution was established in 2019, it aims to reward the individuals who have made significant discoveries in scientific research, promoted scientific development and social progress, or made major breakthroughs in the research and development of key core technologies, and created huge economic and social benefits or ecological environmental benefits. It is the highest award of science and technology in Beijing.

A total of 31 people were nominated for the Zhongguancun Award for Outstanding Contributions. Among them, we are very familiar with many scientists in the field of anti-epidemic, such as Chen Wei, the academician of Chinese Academy of Engineering, who was awarded the "people's hero" national honorary title because of the outstanding contribution in anti-epidemic; Cheng Jing, the academician of Chinese Academy of Engineering, who developed novel coronavirus nucleic acid detection biological chip, etc.; There are also scientists in the fields of computer and artificial intelligence, such as Huang Tiejun, a professor at Peking University and president of the Beijing Academy of Artificial Intelligence, who has set up a new research and development institute to tackle artificial intelligence; and Chen Yunji, a researcher at the Institute of Computing Technology of the Chinese Academy of Sciences, who has developed the world's first dedicated processor chip for deep learning. To be nominated alongside such a high-achieving scientist, Zhao Bo said: " It's the greatest honor."


Profile of Zhao Bo

Zhao Bo, Founder/Chairman of Beijing Biosis Healing Biological Technology  Co., Ltd., Doctor of Surgery, Professor-level Senior Engineer, Postdoctoral Tutor, 2017 Zhongguancun Project Entrepreneurial Leading Talents, 2017 Third Batching of New Innovation Projects • YiQilin Leading Talents in Scientific and Technological Innovation Leading Talents, 2019 Daxing Model, 2020 Daxing District New Gate Scientific and Technological Innovation Leading Talents. As the main completer and project leader, he has successively undertaken major projects in the field of new materials in the “Twelfth Five-Year Plan” of the Ministry of Science and Technology (863 Program), the construction of the “Pharmaceutical Valley No. 1No. 1” public service platform of the National Development and Reform Commission, and the pre-clinical innovation of the Beijing Municipal Science and Technology Commission. Various research project high-precision cultivation of the Zhongguancun National Independent Innovation Demonstration Zone and other research projects. He used to be the deputy chief physician and postgraduate tutor of General Surgery in Beijing Chao-Yang Hospital, Capital Medical University. He has been engaged in clinical and basic research of abdominal surgery for 15 years, saving tens of thousands of patients' lives with superb medical skills and bringing hope to patients' health and well-being.

In 2012, Zhao Bo founded Biosis Healing, and independently developed a biological material named "non-crosslinked extracellular matrix source" (Small Intestinal Submucosa, shortened form SIS material), which is the only regenerative medicine material with platform properties and has advantages of infection resistance and adhesion prevention. It is almost suitable for the regeneration and repair of all soft tissues in human body. However, this material is blank in China and has been monopolized by the United States for a long time. The SIS material used in the surgery of patients can only be imported from abroad at a high price, and most patients cannot afford it.

Breaking the foreign monopoly, the realization of SIS biomaterial localization, became the original intention of Zhao Bo founded Biosis Healing. Over the past 8 years, Zhao Bo has been committed to breaking through the technical problems and industrialization bottlenecks of SIS material preparation, and finally established the core technology system of SIS material with independent intellectual property rights. The products developed are superior to similar materials imported from the United States in terms of technology and performance, reaching the international leading level and breaking the monopoly of the United States. At present, Biosis Healing has become the second enterprise with SIS material preparation technology and the full line of product layout in the world.



Friendship Links:

百度一下   |   京东   |  

版权所有®2019BIOSISHEALING